Geode Capital Management, LLC Standard Biotools Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 6,949,717 shares of LAB stock, worth $13.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,949,717
Previous 6,794,869 2.28%
Holding current value
$13.9 Million
Previous $12 Million 11.53%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$1.42 - $2.35 $219,884 - $363,892
154,848 Added 2.28%
6,949,717 $13.4 Million
Q2 2024

Aug 09, 2024
BUY
$1.65 - $2.92 $6.75 Million - $11.9 Million
4,087,943 Added 151.02%
6,794,869 $12 Million
Q1 2024

May 13, 2024
BUY
$1.87 - $2.78 $3.55 Million - $5.28 Million
1,900,884 Added 235.83%
2,706,926 $7.34 Million
Q4 2023

Feb 13, 2024
BUY
$1.59 - $2.73 $76,682 - $131,662
48,228 Added 6.36%
806,042 $1.78 Million
Q3 2023

Nov 13, 2023
BUY
$1.9 - $3.05 $132,749 - $213,097
69,868 Added 10.16%
757,814 $2.2 Million
Q2 2023

Aug 11, 2023
SELL
$1.47 - $2.56 $38,368 - $66,818
-26,101 Reduced 3.66%
687,946 $1.33 Million
Q1 2023

May 15, 2023
BUY
$1.3 - $2.24 $3,448 - $5,942
2,653 Added 0.37%
714,047 $1.39 Million
Q4 2022

Feb 13, 2023
BUY
$0.93 - $1.52 $3,339 - $5,458
3,591 Added 0.51%
711,394 $832,000
Q3 2022

Nov 14, 2022
BUY
$1.1 - $2.06 $1,360 - $2,548
1,237 Added 0.18%
707,803 $778,000
Q2 2022

Aug 12, 2022
SELL
$1.6 - $3.99 $1.01 Million - $2.52 Million
-632,190 Reduced 47.22%
706,566 $1.13 Million
Q1 2022

May 13, 2022
SELL
$2.8 - $3.96 $103,616 - $146,543
-37,006 Reduced 2.69%
1,338,756 $4.81 Million
Q4 2021

Feb 11, 2022
BUY
$3.63 - $6.13 $94,390 - $159,398
26,003 Added 1.93%
1,375,762 $5.39 Million
Q3 2021

Nov 12, 2021
BUY
$5.5 - $7.41 $208,378 - $280,742
37,887 Added 2.89%
1,349,759 $8.89 Million
Q2 2021

Aug 13, 2021
BUY
$4.35 - $6.35 $186,841 - $272,745
42,952 Added 3.38%
1,311,872 $8.08 Million
Q1 2021

May 12, 2021
BUY
$3.94 - $7.09 $510,025 - $917,786
129,448 Added 11.36%
1,268,920 $5.74 Million
Q4 2020

Feb 12, 2021
BUY
$5.45 - $8.65 $264,728 - $420,165
48,574 Added 4.45%
1,139,472 $6.84 Million
Q3 2020

Nov 13, 2020
BUY
$4.34 - $11.43 $51,993 - $136,931
11,980 Added 1.11%
1,090,898 $8.11 Million
Q2 2020

Aug 13, 2020
BUY
$1.85 - $5.29 $81,015 - $231,659
43,792 Added 4.23%
1,078,918 $4.33 Million
Q1 2020

May 14, 2020
BUY
$1.24 - $4.35 $84,889 - $297,796
68,459 Added 7.08%
1,035,126 $2.63 Million
Q4 2019

Feb 13, 2020
SELL
$2.3 - $5.12 $93,534 - $208,215
-40,667 Reduced 4.04%
966,667 $3.36 Million
Q3 2019

Nov 12, 2019
BUY
$4.63 - $12.15 $923,874 - $2.42 Million
199,541 Added 24.7%
1,007,334 $4.66 Million
Q2 2019

Aug 14, 2019
BUY
$11.49 - $14.17 $1.94 Million - $2.39 Million
168,692 Added 26.4%
807,793 $9.95 Million
Q1 2019

May 14, 2019
BUY
$8.47 - $14.36 $1.58 Million - $2.69 Million
187,044 Added 41.38%
639,101 $8.49 Million
Q4 2018

Feb 13, 2019
BUY
$7.18 - $8.83 $951,701 - $1.17 Million
132,549 Added 41.49%
452,057 $3.9 Million
Q3 2018

Nov 13, 2018
BUY
$5.92 - $8.35 $304,086 - $428,906
51,366 Added 19.16%
319,508 $2.39 Million
Q2 2018

Aug 14, 2018
BUY
$4.86 - $6.24 $55,681 - $71,491
11,457 Added 4.46%
268,142 $1.6 Million
Q1 2018

May 15, 2018
BUY
$5.75 - $7.97 $25,334 - $35,115
4,406 Added 1.75%
256,685 $1.5 Million
Q4 2017

Feb 13, 2018
BUY
$4.46 - $6.45 $95,573 - $138,217
21,429 Added 9.28%
252,279 $1.49 Million
Q3 2017

Nov 14, 2017
SELL
$3.55 - $5.49 $42,699 - $66,033
-12,028 Reduced 4.95%
230,850 $1.16 Million
Q2 2017

Aug 14, 2017
BUY
N/A
242,878
242,878 $980,000

Others Institutions Holding LAB

# of Institutions
142
Shares Held
279M
Call Options Held
27.2K
Put Options Held
34.1K
View Full List

About STANDARD BIOTOOLS INC.

LAB Quotes by TradingView
  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $157M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email